Hemorrhagic cystitis
Hemorrhagic cystitis refers to acute or chronic damage to the bladder caused by certain drugs or chemicals in the urine, leading to extensive inflammatory bleeding in the bladder. This disease is a multi-cause complication that is common in cancer patients during treatment. It is mostly caused by toxicity or allergic reactions to anti-tumor drugs, radiation damage caused by high-dose pelvic irradiation, and also seen in certain viral infections, such as adenovirus and influenza virus infections.
-
Site of disease:
Bladder blood vessels -
Infectious :
Not contagious -
Frequent population:
Exposure to alkylating agents is common
Related Drugs
Mesna Injection
Indication: This product can prevent urinary epithelial toxicity such as hemorrhagic cystitis caused by high-dose ifosfamide or cyclophosphamide for tumor chemotherapy. It works together with anti-tumor chemotherapy drugs ifosfamide or cyclophosphamide as a urinary system protector.
Mesna Injection
Indication: This product can prevent urinary epithelial toxicity such as hemorrhagic cystitis caused by high-dose ifosfamide or cyclophosphamide for tumor chemotherapy. It works together with anti-tumor chemotherapy drugs ifosfamide or cyclophosphamide as a urinary system protector.
Manufacturer:
Shanxi PUDE Pharmaceutical Co., Ltd.
Mesna Injection
Indication: This product can prevent urinary epithelial toxicity such as hemorrhagic cystitis caused by high-dose ifosfamide or cyclophosphamide for tumor chemotherapy. It works together with anti-tumor chemotherapy drugs ifosfamide or cyclophosphamide as a urinary system protector.
Manufacturer:
Qilu Pharmaceutical (Hainan) Co., Ltd.
Related Ingredients